462 related articles for article (PubMed ID: 21809356)
1. Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice.
Li L; Chen L; Hu L; Liu Y; Sun HY; Tang J; Hou YJ; Chang YX; Tu QQ; Feng GS; Shen F; Wu MC; Wang HY
Hepatology; 2011 Nov; 54(5):1620-30. PubMed ID: 21809356
[TBL] [Abstract][Full Text] [Related]
2. High mobility group box 1 activates Toll like receptor 4 signaling in hepatic stellate cells.
Zhang Z; Lin C; Peng L; Ouyang Y; Cao Y; Wang J; Friedman SL; Guo J
Life Sci; 2012 Sep; 91(5-6):207-12. PubMed ID: 22841886
[TBL] [Abstract][Full Text] [Related]
3. The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88.
Hritz I; Mandrekar P; Velayudham A; Catalano D; Dolganiuc A; Kodys K; Kurt-Jones E; Szabo G
Hepatology; 2008 Oct; 48(4):1224-31. PubMed ID: 18792393
[TBL] [Abstract][Full Text] [Related]
4. High-mobility group box 1 (HMGB1)-Toll-like receptor (TLR)4-interleukin (IL)-23-IL-17A axis in drug-induced damage-associated lethal hepatitis: Interaction of γδ T cells with macrophages.
Wang X; Sun R; Wei H; Tian Z
Hepatology; 2013 Jan; 57(1):373-84. PubMed ID: 22821628
[TBL] [Abstract][Full Text] [Related]
5. High mobility group box 1 promotes small intestinal damage induced by nonsteroidal anti-inflammatory drugs through Toll-like receptor 4.
Nadatani Y; Watanabe T; Tanigawa T; Machida H; Okazaki H; Yamagami H; Watanabe K; Tominaga K; Fujiwara Y; Arakawa T
Am J Pathol; 2012 Jul; 181(1):98-110. PubMed ID: 22634181
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice.
Spruss A; Kanuri G; Wagnerberger S; Haub S; Bischoff SC; Bergheim I
Hepatology; 2009 Oct; 50(4):1094-104. PubMed ID: 19637282
[TBL] [Abstract][Full Text] [Related]
7. HMGB1 was negatively regulated by HSF1 and mediated the TLR4/MyD88/NF-κB signal pathway in asthma.
Shang L; Wang L; Shi X; Wang N; Zhao L; Wang J; Liu C
Life Sci; 2020 Jan; 241():117120. PubMed ID: 31825792
[TBL] [Abstract][Full Text] [Related]
8. The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules.
Mudaliar H; Pollock C; Komala MG; Chadban S; Wu H; Panchapakesan U
Am J Physiol Renal Physiol; 2013 Jul; 305(2):F143-54. PubMed ID: 23576640
[TBL] [Abstract][Full Text] [Related]
9. Cross talk between toll-like receptor-4 signaling and angiotensin-II in liver fibrosis development in the rat model of non-alcoholic steatohepatitis.
Shirai Y; Yoshiji H; Noguchi R; Kaji K; Aihara Y; Douhara A; Moriya K; Namisaki T; Kawaratani H; Fukui H
J Gastroenterol Hepatol; 2013 Apr; 28(4):723-30. PubMed ID: 23301938
[TBL] [Abstract][Full Text] [Related]
10. Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration.
Seki E; Tsutsui H; Iimuro Y; Naka T; Son G; Akira S; Kishimoto T; Nakanishi K; Fujimoto J
Hepatology; 2005 Mar; 41(3):443-50. PubMed ID: 15723296
[TBL] [Abstract][Full Text] [Related]
11. Melatonin modulates TLR4-mediated inflammatory genes through MyD88- and TRIF-dependent signaling pathways in lipopolysaccharide-stimulated RAW264.7 cells.
Xia MZ; Liang YL; Wang H; Chen X; Huang YY; Zhang ZH; Chen YH; Zhang C; Zhao M; Xu DX; Song LH
J Pineal Res; 2012 Nov; 53(4):325-34. PubMed ID: 22537289
[TBL] [Abstract][Full Text] [Related]
12. [HMGB1-mediated activation of TLR4 signaling in hepatic stellate cells].
Zhang Z; Lin CZ; Peng LJ; Ouyang YY; Cao YR; Guo JS
Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):581-4. PubMed ID: 23207150
[TBL] [Abstract][Full Text] [Related]
13. Expression of high mobility group B1 and toll-like receptor-nuclear factor κB signaling pathway in chronic subdural hematomas.
Osuka K; Watanabe Y; Usuda N; Iwami K; Miyachi S; Takayasu M
PLoS One; 2020; 15(6):e0233643. PubMed ID: 32479555
[TBL] [Abstract][Full Text] [Related]
14. The toll-like receptor 4-mediated signaling pathway is activated following optic nerve injury in mice.
Zheng Z; Yuan R; Song M; Huo Y; Liu W; Cai X; Zou H; Chen C; Ye J
Brain Res; 2012 Dec; 1489():90-7. PubMed ID: 23103505
[TBL] [Abstract][Full Text] [Related]
15. TLR4 activation mediates kidney ischemia/reperfusion injury.
Wu H; Chen G; Wyburn KR; Yin J; Bertolino P; Eris JM; Alexander SI; Sharland AF; Chadban SJ
J Clin Invest; 2007 Oct; 117(10):2847-59. PubMed ID: 17853945
[TBL] [Abstract][Full Text] [Related]
16. Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NFκB signaling, MAPK, and Jak1/Stat1 pathways.
Gorina R; Font-Nieves M; Márquez-Kisinousky L; Santalucia T; Planas AM
Glia; 2011 Feb; 59(2):242-55. PubMed ID: 21125645
[TBL] [Abstract][Full Text] [Related]
17. Interferon regulatory factor 1 mediates acetylation and release of high mobility group box 1 from hepatocytes during murine liver ischemia-reperfusion injury.
Dhupar R; Klune JR; Evankovich J; Cardinal J; Zhang M; Ross M; Murase N; Geller DA; Billiar TR; Tsung A
Shock; 2011 Mar; 35(3):293-301. PubMed ID: 20856174
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice.
Ye D; Li FY; Lam KS; Li H; Jia W; Wang Y; Man K; Lo CM; Li X; Xu A
Gut; 2012 Jul; 61(7):1058-67. PubMed ID: 22253482
[TBL] [Abstract][Full Text] [Related]
19. Glycine attenuates endotoxin-induced liver injury by downregulating TLR4 signaling in Kupffer cells.
Xu FL; You HB; Li XH; Chen XF; Liu ZJ; Gong JP
Am J Surg; 2008 Jul; 196(1):139-48. PubMed ID: 18565339
[TBL] [Abstract][Full Text] [Related]
20. Knockout of toll-like receptor-4 attenuates the pro-inflammatory state of diabetes.
Devaraj S; Tobias P; Jialal I
Cytokine; 2011 Sep; 55(3):441-5. PubMed ID: 21498084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
